ArticleVeterinary medicine and science2025
Unraveling Genetic Diversity and Antibiotic Resistance Mechanisms in Citrobacter freundii Isolates From Meat Products: Implications for Food Safety and Public Health.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Genomic epidemiology ofOne health (Amsterdam, Netherlands) · 2026Article
- Unraveling Genetic Diversity and Antibiotic Resistance Mechanisms in Citrobacter freundii Isolates From Meat Products: Implications for Food Safety and Public Health.Veterinary medicine and science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Citrobacter freundii is a zoonotic bacterium with special public health importance as a carrier and source of multidrug resistance (MDR) genes. Here, the prevalence, genetic heterogeneity, and antimicrobial resistance pattern of C. freundii from chicken and red meat in Shahrekord, Iran, were examined. Cross-sectional design and a combination of molecular methods with random amplified polymorphic DNA (RAPD-PCR), enterobacterial repetitive intergenic consensus (ERIC-PCR), and repetitive extragenic palindromic PCR (REP-PCR) and phenotypic methods were used for identifying genotypic patterns and resistance markers such as bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.